Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - Anthera Pharmaceuticals Inc | f59192e10vq.htm |
| EX-31.2 - EX-31.2 - Anthera Pharmaceuticals Inc | f59192exv31w2.htm |
| EX-32.2 - EX-32.2 - Anthera Pharmaceuticals Inc | f59192exv32w2.htm |
| EX-31.1 - EX-31.1 - Anthera Pharmaceuticals Inc | f59192exv31w1.htm |
| EX-10.4 - EX-10.4 - Anthera Pharmaceuticals Inc | f59192exv10w4.htm |
Exhibit 32.1
Certification Pursuant to
Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350
Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350
I, Paul F. Truex, certify, pursuant to the requirement set forth in Rule 13a-14(b) of the
Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Anthera
Pharmaceuticals, Inc. on Form 10-Q for the quarter ending March 31, 2011 fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information
contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the
financial condition and results of operations of Anthera Pharmaceuticals, Inc.
| By: | /s/ Paul F. Truex | |||
| Name: | Paul F. Truex | |||
| Title: | President and Chief Executive Officer | |||
Date: May 13, 2011